Giant Biogene Holding Co (HKSE:02367) Earnings per Share (Diluted) : HK$1.62 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Earnings per Share (Diluted)?

Giant Biogene Holding Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.90. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.62.

Giant Biogene Holding Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.90. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.63.

Giant Biogene Holding Co's EPS without NRI for the six months ended in Dec. 2023 was HK$0.87. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.59.

During the past 12 months, Giant Biogene Holding Co's average EPS without NRIGrowth Rate was 44.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 24.30% per year.

During the past 5 years, Giant Biogene Holding Co's highest 3-Year average EPS without NRI Growth Rate was 24.30% per year. The lowest was 20.50% per year. And the median was 22.40% per year.

Giant Biogene Holding Co Earnings per Share (Diluted) Historical Data

The historical data trend for Giant Biogene Holding Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Earnings per Share (Diluted) Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

0.62

0.99

1.02

1.09

1.62

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial			1.02	0.52	0.63	0.72	0.90

Competitive Comparison of Giant Biogene Holding Co's Earnings per Share (Diluted)

For the Household & Personal Products subindustry, Giant Biogene Holding Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's PE Ratio falls into.

Giant Biogene Holding Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Giant Biogene Holding Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(1587.897	-	0)	/	982.717
	=	1.62

Giant Biogene Holding Co's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(858.412	-	0)	/	959.742
	=	0.89

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.62

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Giant Biogene Holding Co (HKSE:02367) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Giant Biogene Holding Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines